These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4064249)

  • 1. Chemical carcinogens as specific inducers of a 60-kilodalton oncofetal protein in rats.
    Hanausek-Walaszek M; Walaszek Z; Webb TE
    Carcinogenesis; 1985 Dec; 6(12):1725-30. PubMed ID: 4064249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological identity of a 60 kd oncofetal protein induced in rats by chemical carcinogens and released by transformed cells.
    Hanausek-Walaszek M; Lang RW; Walaszek Z; Webb TE
    Biochem Biophys Res Commun; 1985 Mar; 127(3):779-85. PubMed ID: 2580518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correspondence between biochemical and antigenic activity of a 60 kilodalton oncofetal protein during carcinogenesis and tumorigenesis.
    Hanausek-Walaszek M; Montgomery N; Walaszek Z; Long RW; Webb TS
    Cancer Lett; 1986 Oct; 33(1):55-61. PubMed ID: 2429761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.
    Elcombe CR; Odum J; Foster JR; Stone S; Hasmall S; Soames AR; Kimber I; Ashby J
    Environ Health Perspect; 2002 Apr; 110(4):363-75. PubMed ID: 11940454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
    Nioi P; Pardo ID; Sherratt PJ; Snyder RD
    Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression by sustained-release beta-glucuronidase inhibitors of chemical carcinogen-mediated induction of a marker oncofetal protein in rodents.
    Walaszek Z; Hanausek-Walaszek M; Webb TE
    J Toxicol Environ Health; 1988; 23(1):15-27. PubMed ID: 3336058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 60 kilodalton oncofetal protein as tumor marker.
    Hanausek-Walaszek M; Walaszek Z; Webb TE
    J Med; 1986; 17(1):13-23. PubMed ID: 3473154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of various chemicals for initiating and promoting activities in a short-term in vivo system based on generation of hyperplastic liver nodules in rats.
    Tatematsu M; Hasegawa R; Imaida K; Tsuda H; Ito N
    Carcinogenesis; 1983; 4(4):381-6. PubMed ID: 6301702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
    Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
    Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comet assay evaluation of six chemicals of known genotoxic potential in rats.
    Hobbs CA; Recio L; Streicker M; Boyle MH; Tanaka J; Shiga A; Witt KL
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Jul; 786-788():172-81. PubMed ID: 26212309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are genotoxic carcinogens more potent than nongenotoxic carcinogens?
    Parodi S; Malacarne D; Romano P; Taningher M
    Environ Health Perspect; 1991 Nov; 95():199-204. PubMed ID: 1821372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a 60,000-dalton oncofetal protein from the plasma of tumor-bearing rats.
    Hanausek-Walaszek M; Walaszek Z; Lang RW; Webb TE
    Cancer Invest; 1984; 2(6):433-41. PubMed ID: 6210134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.